> top > docs > PubMed:23952588 > annotations

PubMed:23952588 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCoin-sentences

Id Subject Object Predicate Lexical cue
T12 728-772 Sentence denotes The median disease duration was 6 (7) years.
T13 773-852 Sentence denotes Dyskinesia was present in 44% (n = 42) with median levodopa therapy of 3 years.
T14 853-932 Sentence denotes There were 64.3% Chinese, 31% Malays, and 3.7% Indians and other ethnic groups.
T15 933-1006 Sentence denotes Eighty-one percent of patients with dyskinesia had clinical fluctuations.
T16 1007-1277 Sentence denotes Patients with dyskinesia had lower onset age ( p < 0.001), longer duration of levodopa therapy ( p < 0.001), longer disease duration ( p < 0.001), higher total daily levodopa dose ( p < 0.001), and higher total UPDRS scores ( p = 0.005) than patients without dyskinesia.
T17 1278-1401 Sentence denotes The three significant predictors of dyskinesia were duration of levodopa therapy, onset age, and total daily levodopa dose.
T18 1402-1414 Sentence denotes CONCLUSIONS:
T4 253-370 Sentence denotes We studied the prevalence and predictors of levodopa-induced dyskinesia among multiethnic Malaysian patients with PD.
T5 371-379 Sentence denotes METHODS:
T6 380-498 Sentence denotes This is a cross-sectional study involving 95 patients with PD on uninterrupted levodopa therapy for at least 6 months.
T7 499-548 Sentence denotes The instrument used was the UPDRS questionnaires.
T8 549-642 Sentence denotes The predictors of dyskinesia were determined using multivariate logistic regression analysis.
T9 643-651 Sentence denotes RESULTS:
T10 652-686 Sentence denotes The mean age was 65.6 ± 8.5 years.
T11 687-727 Sentence denotes The mean onset age was 58.5 ± 9.8 years.
T1 0-113 Sentence denotes Risk factors and predictors of levodopa-induced dyskinesia among multiethnic Malaysians with Parkinson's disease.
T2 114-125 Sentence denotes UNLABELLED:
T3 126-252 Sentence denotes Chronic pulsatile levodopa therapy for Parkinson's disease (PD) leads to the development of motor fluctuations and dyskinesia.
T19 1415-1485 Sentence denotes The prevalence of levodopa-induced dyskinesia in our patients was 44%.
T20 1486-1594 Sentence denotes The most significant predictors were duration of levodopa therapy, total daily levodopa dose, and onset age.

LitCoin-entities

Id Subject Object Predicate Lexical cue db_id
9323 31-39 ChemicalEntity denotes levodopa MESH:D007980
9324 48-58 DiseaseOrPhenotypicFeature denotes dyskinesia MESH:D004409
9325 93-112 DiseaseOrPhenotypicFeature denotes Parkinson's disease MESH:D010300
9326 144-152 ChemicalEntity denotes levodopa MESH:D007980
9327 165-184 DiseaseOrPhenotypicFeature denotes Parkinson's disease MESH:D010300
9328 186-188 DiseaseOrPhenotypicFeature denotes PD MESH:D010300
9329 241-251 DiseaseOrPhenotypicFeature denotes dyskinesia MESH:D004409
9330 297-305 ChemicalEntity denotes levodopa MESH:D007980
9331 314-324 DiseaseOrPhenotypicFeature denotes dyskinesia MESH:D004409
9332 353-361 OrganismTaxon denotes patients NCBITaxon:9606
9333 367-369 DiseaseOrPhenotypicFeature denotes PD MESH:D010300
9334 425-433 OrganismTaxon denotes patients NCBITaxon:9606
9335 439-441 DiseaseOrPhenotypicFeature denotes PD MESH:D010300
9336 459-467 ChemicalEntity denotes levodopa MESH:D007980
9337 567-577 DiseaseOrPhenotypicFeature denotes dyskinesia MESH:D004409
9338 773-783 DiseaseOrPhenotypicFeature denotes Dyskinesia MESH:D004409
9339 824-832 ChemicalEntity denotes levodopa MESH:D007980
9340 955-963 OrganismTaxon denotes patients NCBITaxon:9606
9341 969-979 DiseaseOrPhenotypicFeature denotes dyskinesia MESH:D004409
9342 1007-1015 OrganismTaxon denotes Patients NCBITaxon:9606
9343 1021-1031 DiseaseOrPhenotypicFeature denotes dyskinesia MESH:D004409
9344 1085-1093 ChemicalEntity denotes levodopa MESH:D007980
9345 1173-1181 ChemicalEntity denotes levodopa MESH:D007980
9346 1249-1257 OrganismTaxon denotes patients NCBITaxon:9606
9347 1266-1276 DiseaseOrPhenotypicFeature denotes dyskinesia MESH:D004409
9348 1314-1324 DiseaseOrPhenotypicFeature denotes dyskinesia MESH:D004409
9349 1342-1350 ChemicalEntity denotes levodopa MESH:D007980
9350 1387-1395 ChemicalEntity denotes levodopa MESH:D007980
9351 1433-1441 ChemicalEntity denotes levodopa MESH:D007980
9352 1450-1460 DiseaseOrPhenotypicFeature denotes dyskinesia MESH:D004409
9353 1468-1476 OrganismTaxon denotes patients NCBITaxon:9606
9354 1535-1543 ChemicalEntity denotes levodopa MESH:D007980
9355 1565-1573 ChemicalEntity denotes levodopa MESH:D007980

LitCoin_Mondo

Id Subject Object Predicate Lexical cue mondo_id
T1 93-112 DiseaseOrPhenotypicFeature denotes Parkinson's disease 0005180
T2 165-184 DiseaseOrPhenotypicFeature denotes Parkinson's disease 0005180

LitCoin-GeneOrGeneProduct-v0

Id Subject Object Predicate Lexical cue
T1 5-12 GeneOrGeneProduct denotes factors
T2 40-47 GeneOrGeneProduct denotes induced
T3 218-223 GeneOrGeneProduct denotes motor
T4 306-313 GeneOrGeneProduct denotes induced
T5 371-378 GeneOrGeneProduct denotes METHODS
T6 583-593 GeneOrGeneProduct denotes determined
T7 680-685 GeneOrGeneProduct denotes years
T8 721-726 GeneOrGeneProduct denotes years
T9 766-771 GeneOrGeneProduct denotes years
T10 846-851 GeneOrGeneProduct denotes years
T11 912-917 GeneOrGeneProduct denotes other
T12 1161-1166 GeneOrGeneProduct denotes total
T13 1212-1217 GeneOrGeneProduct denotes total
T14 1375-1380 GeneOrGeneProduct denotes total
T15 1442-1449 GeneOrGeneProduct denotes induced
T16 1553-1558 GeneOrGeneProduct denotes total

LitCoin-GeneOrGeneProduct-v2

Id Subject Object Predicate Lexical cue
T1 218-223 GeneOrGeneProduct denotes motor
T2 912-917 GeneOrGeneProduct denotes other

LitCoin-Disease-MeSH

Id Subject Object Predicate Lexical cue originalLabel
T1 48-58 DiseaseOrPhenotypicFeature denotes dyskinesia D020820
T2 93-112 DiseaseOrPhenotypicFeature denotes Parkinson's disease D010300
T3 165-184 DiseaseOrPhenotypicFeature denotes Parkinson's disease D010300
T4 186-188 DiseaseOrPhenotypicFeature denotes PD D010300
T5 241-251 DiseaseOrPhenotypicFeature denotes dyskinesia D020820
T6 314-324 DiseaseOrPhenotypicFeature denotes dyskinesia D020820
T7 367-369 DiseaseOrPhenotypicFeature denotes PD D010300
T8 439-441 DiseaseOrPhenotypicFeature denotes PD D010300
T9 567-577 DiseaseOrPhenotypicFeature denotes dyskinesia D020820
T10 739-746 DiseaseOrPhenotypicFeature denotes disease D004194
T11 773-783 DiseaseOrPhenotypicFeature denotes Dyskinesia D020820
T12 969-979 DiseaseOrPhenotypicFeature denotes dyskinesia D020820
T13 1021-1031 DiseaseOrPhenotypicFeature denotes dyskinesia D020820
T14 1123-1130 DiseaseOrPhenotypicFeature denotes disease D004194
T15 1266-1276 DiseaseOrPhenotypicFeature denotes dyskinesia D020820
T16 1314-1324 DiseaseOrPhenotypicFeature denotes dyskinesia D020820
T17 1450-1460 DiseaseOrPhenotypicFeature denotes dyskinesia D020820

LitCoin_Mondo_095

Id Subject Object Predicate Lexical cue mondo_id
T1 93-112 DiseaseOrPhenotypicFeature denotes Parkinson's disease 0005180
T2 165-184 DiseaseOrPhenotypicFeature denotes Parkinson's disease 0005180
T3 186-188 DiseaseOrPhenotypicFeature denotes PD 0015873|0008199|0005180
T6 367-369 DiseaseOrPhenotypicFeature denotes PD 0015873|0008199|0005180
T9 439-441 DiseaseOrPhenotypicFeature denotes PD 0015873|0008199|0005180

LitCoin-MeSH-Disease-2

Id Subject Object Predicate Lexical cue ID:
T1 48-58 DiseaseOrPhenotypicFeature denotes dyskinesia D020820
T2 93-112 DiseaseOrPhenotypicFeature denotes Parkinson's disease D010300
T3 165-184 DiseaseOrPhenotypicFeature denotes Parkinson's disease D010300
T4 186-188 DiseaseOrPhenotypicFeature denotes PD D010300
T5 241-251 DiseaseOrPhenotypicFeature denotes dyskinesia D020820
T6 314-324 DiseaseOrPhenotypicFeature denotes dyskinesia D020820
T7 367-369 DiseaseOrPhenotypicFeature denotes PD D010300
T8 439-441 DiseaseOrPhenotypicFeature denotes PD D010300
T9 567-577 DiseaseOrPhenotypicFeature denotes dyskinesia D020820
T10 739-746 DiseaseOrPhenotypicFeature denotes disease D004194
T11 773-783 DiseaseOrPhenotypicFeature denotes Dyskinesia D020820
T12 969-979 DiseaseOrPhenotypicFeature denotes dyskinesia D020820
T13 1021-1031 DiseaseOrPhenotypicFeature denotes dyskinesia D020820
T14 1123-1130 DiseaseOrPhenotypicFeature denotes disease D004194
T15 1266-1276 DiseaseOrPhenotypicFeature denotes dyskinesia D020820
T16 1314-1324 DiseaseOrPhenotypicFeature denotes dyskinesia D020820
T17 1450-1460 DiseaseOrPhenotypicFeature denotes dyskinesia D020820

LitCoin-MONDO_bioort2019

Id Subject Object Predicate Lexical cue #label
T1 48-58 DiseaseOrPhenotypicFeature denotes dyskinesia D020820
T2 93-112 DiseaseOrPhenotypicFeature denotes Parkinson's disease D010300
T3 165-184 DiseaseOrPhenotypicFeature denotes Parkinson's disease D010300
T4 186-188 DiseaseOrPhenotypicFeature denotes PD D010300
T5 241-251 DiseaseOrPhenotypicFeature denotes dyskinesia D020820
T6 314-324 DiseaseOrPhenotypicFeature denotes dyskinesia D020820
T7 367-369 DiseaseOrPhenotypicFeature denotes PD D010300
T8 439-441 DiseaseOrPhenotypicFeature denotes PD D010300
T9 567-577 DiseaseOrPhenotypicFeature denotes dyskinesia D020820
T10 773-783 DiseaseOrPhenotypicFeature denotes Dyskinesia D020820
T11 969-979 DiseaseOrPhenotypicFeature denotes dyskinesia D020820
T12 1021-1031 DiseaseOrPhenotypicFeature denotes dyskinesia D020820
T13 1266-1276 DiseaseOrPhenotypicFeature denotes dyskinesia D020820
T14 1314-1324 DiseaseOrPhenotypicFeature denotes dyskinesia D020820
T15 1450-1460 DiseaseOrPhenotypicFeature denotes dyskinesia D020820

LitCoin-Chemical-MeSH-CHEBI

Id Subject Object Predicate Lexical cue ID:
T1 31-39 ChemicalEntity denotes levodopa http://purl.obolibrary.org/obo/CHEBI_15765
T2 144-152 ChemicalEntity denotes levodopa http://purl.obolibrary.org/obo/CHEBI_15765
T3 297-305 ChemicalEntity denotes levodopa http://purl.obolibrary.org/obo/CHEBI_15765
T4 459-467 ChemicalEntity denotes levodopa http://purl.obolibrary.org/obo/CHEBI_15765
T5 824-832 ChemicalEntity denotes levodopa http://purl.obolibrary.org/obo/CHEBI_15765
T6 1085-1093 ChemicalEntity denotes levodopa http://purl.obolibrary.org/obo/CHEBI_15765
T7 1173-1181 ChemicalEntity denotes levodopa http://purl.obolibrary.org/obo/CHEBI_15765
T8 1342-1350 ChemicalEntity denotes levodopa http://purl.obolibrary.org/obo/CHEBI_15765
T9 1387-1395 ChemicalEntity denotes levodopa http://purl.obolibrary.org/obo/CHEBI_15765
T10 1433-1441 ChemicalEntity denotes levodopa http://purl.obolibrary.org/obo/CHEBI_15765
T11 1535-1543 ChemicalEntity denotes levodopa http://purl.obolibrary.org/obo/CHEBI_15765
T12 1565-1573 ChemicalEntity denotes levodopa http://purl.obolibrary.org/obo/CHEBI_15765

LitCoin-NCBITaxon-2

Id Subject Object Predicate Lexical cue
T1 353-361 OrganismTaxon denotes patients
T2 425-433 OrganismTaxon denotes patients
T3 955-963 OrganismTaxon denotes patients
T4 1249-1257 OrganismTaxon denotes patients
T5 1468-1476 OrganismTaxon denotes patients

LitCoin-training-merged

Id Subject Object Predicate Lexical cue #label ID:
T12 1565-1573 ChemicalEntity denotes levodopa http://purl.obolibrary.org/obo/CHEBI_15765
T11 1535-1543 ChemicalEntity denotes levodopa http://purl.obolibrary.org/obo/CHEBI_15765
T10 1433-1441 ChemicalEntity denotes levodopa http://purl.obolibrary.org/obo/CHEBI_15765
T9 1387-1395 ChemicalEntity denotes levodopa http://purl.obolibrary.org/obo/CHEBI_15765
T8 1342-1350 ChemicalEntity denotes levodopa http://purl.obolibrary.org/obo/CHEBI_15765
T7 1173-1181 ChemicalEntity denotes levodopa http://purl.obolibrary.org/obo/CHEBI_15765
T6 1085-1093 ChemicalEntity denotes levodopa http://purl.obolibrary.org/obo/CHEBI_15765
T5 824-832 ChemicalEntity denotes levodopa http://purl.obolibrary.org/obo/CHEBI_15765
T4 459-467 ChemicalEntity denotes levodopa http://purl.obolibrary.org/obo/CHEBI_15765
T3 297-305 ChemicalEntity denotes levodopa http://purl.obolibrary.org/obo/CHEBI_15765
T2 144-152 ChemicalEntity denotes levodopa http://purl.obolibrary.org/obo/CHEBI_15765
T1 31-39 ChemicalEntity denotes levodopa http://purl.obolibrary.org/obo/CHEBI_15765
T15 1450-1460 DiseaseOrPhenotypicFeature denotes dyskinesia D020820
T14 1314-1324 DiseaseOrPhenotypicFeature denotes dyskinesia D020820
T13 1266-1276 DiseaseOrPhenotypicFeature denotes dyskinesia D020820
T74208 1021-1031 DiseaseOrPhenotypicFeature denotes dyskinesia D020820
T35478 969-979 DiseaseOrPhenotypicFeature denotes dyskinesia D020820
T5569 773-783 DiseaseOrPhenotypicFeature denotes Dyskinesia D020820
T52246 567-577 DiseaseOrPhenotypicFeature denotes dyskinesia D020820
T37935 439-441 DiseaseOrPhenotypicFeature denotes PD D010300
T68808 367-369 DiseaseOrPhenotypicFeature denotes PD D010300
T66222 314-324 DiseaseOrPhenotypicFeature denotes dyskinesia D020820
T97672 241-251 DiseaseOrPhenotypicFeature denotes dyskinesia D020820
T32839 186-188 DiseaseOrPhenotypicFeature denotes PD D010300
T55506 165-184 DiseaseOrPhenotypicFeature denotes Parkinson's disease D010300
T50074 93-112 DiseaseOrPhenotypicFeature denotes Parkinson's disease D010300
T27873 48-58 DiseaseOrPhenotypicFeature denotes dyskinesia D020820
T17364 1468-1476 OrganismTaxon denotes patients
T62467 1249-1257 OrganismTaxon denotes patients
T68721 955-963 OrganismTaxon denotes patients
T28904 425-433 OrganismTaxon denotes patients
T49537 353-361 OrganismTaxon denotes patients

Allie

Id Subject Object Predicate Lexical cue
SS1_23952588_2_0 165-184 expanded denotes Parkinson's disease
SS2_23952588_2_0 186-188 abbr denotes PD
AE1_23952588_2_0 SS1_23952588_2_0 SS2_23952588_2_0 abbreviatedTo Parkinson's disease,PD

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 165-174 HP_0001300 denotes Parkinson
T2 241-251 HP_0100660 denotes dyskinesia
T3 314-324 HP_0100660 denotes dyskinesia